Common variation near ROBO2 is associated with expressive vocabulary in infancy
Beaté St Pourcain(University of Bristol), George Davey Smith(University of Bristol), Robert Plomin(King's College London), Oliver S. P. Davis(Medizinische Hochschule Hannover), Jean Golding(University of Bristol), Vincent W. V. Jaddoe(Erasmus MC), Nicole M. Warrington(The University of Western Australia), Andrew Whitehouse(The Kids Research Institute Australia), Fernando Rivadeneira(Erasmus MC), Paul F. O’Reilly(Icahn School of Medicine at Mount Sinai), John P. Kemp(Translational Research Institute), Albert Hofman(Harvard University), Emma L. Meaburn(King's College London), Rolieke A.M. Cents(Erasmus MC), Anneli Yliherva(University of Oulu), Fleur P. Velders(Erasmus MC), Nicholas J. Timpson(University of Bristol), Philip S. Dale(University of New Mexico), Thomas S. Price(Translational Therapeutics (United States)), Marjo‐Riitta Järvelin(Imperial College London), Q. W. Ang(The University of Western Australia), Demetris Pillas(Public Health England), Henning Tiemeier(Harvard University), Craig E. Pennell(The University of Western Australia), Frank C. Verhulst(Erasmus MC), Claire M. A. Haworth(University of Bristol), Yvonne Wren(University of Bristol), David M. Evans(The University of Queensland), Laura L. Miller(Google (United States)), Alina Rodriguez(Agency for Science, Technology and Research), Susan Roulstone(University of the West of England), Susan M. Ring(St George's, University of London)
Cited by 96
Related Papers
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.6k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Large-scale association analyses identify host factors influencing human gut microbiome composition
|Nature Genetics|2021|1.9k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k